These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 20214255)

  • 1. Consumers' views on generic medicines: a review of the literature.
    Hassali MA; Shafie AA; Jamshed S; Ibrahim MI; Awaisu A
    Int J Pharm Pract; 2009 Apr; 17(2):79-88. PubMed ID: 20214255
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A survey exploring knowledge and perceptions of general practitioners towards the use of generic medicines in the northern state of Malaysia.
    Chua GN; Hassali MA; Shafie AA; Awaisu A
    Health Policy; 2010 May; 95(2-3):229-35. PubMed ID: 20044165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interventions promoting the acceptance and uptake of generic medicines: a narrative review of the literature.
    Babar ZU; Kan SW; Scahill S
    Health Policy; 2014 Sep; 117(3):285-96. PubMed ID: 24973926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluating pharmacists' views, knowledge, and perception regarding generic medicines in New Zealand.
    Babar ZU; Grover P; Stewart J; Hogg M; Short L; Seo HG; Rew A
    Res Social Adm Pharm; 2011 Sep; 7(3):294-305. PubMed ID: 21272551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 'Not the full Monty': a qualitative study of seniors' perceptions of generic medicines in Western Australia.
    Bulsara C; McKenzie A; Sanfilippo F; Holman CD; Emery JE
    Aust J Prim Health; 2010; 16(3):240-5. PubMed ID: 20815994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generic drug prices and policy in Australia: room for improvement? a comparative analysis with England.
    Mansfield SJ
    Aust Health Rev; 2014 Feb; 38(1):6-15. PubMed ID: 24480618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Policies to promote use of generic medicines in low and middle income countries: a review of published literature, 2000-2010.
    Kaplan WA; Ritz LS; Vitello M; Wirtz VJ
    Health Policy; 2012 Aug; 106(3):211-24. PubMed ID: 22694970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of the Minimum Pricing Policy and introduction of brand (generic) substitution into the Pharmaceutical Benefits Scheme in Australia.
    McManus P; Birkett DJ; Dudley J; Stevens A
    Pharmacoepidemiol Drug Saf; 2001; 10(4):295-300. PubMed ID: 11760489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The economics of pediatric formulation development for off-patent drugs.
    Milne CP; Bruss JB
    Clin Ther; 2008 Nov; 30(11):2133-45. PubMed ID: 19108801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perspectives of physicians practicing in low and middle income countries towards generic medicines: a narrative review.
    Hassali MA; Wong ZY; Alrasheedy AA; Saleem F; Mohamad Yahaya AH; Aljadhey H
    Health Policy; 2014 Sep; 117(3):297-310. PubMed ID: 25129135
    [TBL] [Abstract][Full Text] [Related]  

  • 11. What Do Users of Generic Medicines Think of Them? A Systematic Review of Consumers' and Patients' Perceptions of, and Experiences with, Generic Medicines.
    Dunne SS
    Patient; 2016 Dec; 9(6):499-510. PubMed ID: 27142371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluating community pharmacists' perceptions of future generic substitution policy implementation: a national survey from Malaysia.
    Chong CP; Hassali MA; Bahari MB; Shafie AA
    Health Policy; 2010 Jan; 94(1):68-75. PubMed ID: 19762106
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of generic competition on the price of brand-name drugs.
    Lexchin J
    Health Policy; 2004 Apr; 68(1):47-54. PubMed ID: 15033552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Demand-side policies to encourage the use of generic medicines: an overview.
    Dylst P; Vulto A; Simoens S
    Expert Rev Pharmacoecon Outcomes Res; 2013 Feb; 13(1):59-72. PubMed ID: 23402447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Consumer perception on generic medicines in Basrah, Iraq: preliminary findings from a qualitative study.
    Sharrad AK; Hassali MA
    Res Social Adm Pharm; 2011 Mar; 7(1):108-12. PubMed ID: 21397885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. "This body does not want free medicines": South African consumer perceptions of drug quality.
    Patel A; Gauld R; Norris P; Rades T
    Health Policy Plan; 2010 Jan; 25(1):61-9. PubMed ID: 19726560
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adherence to multiple, prescribed medications in diabetic kidney disease: A qualitative study of consumers' and health professionals' perspectives.
    Williams AF; Manias E; Walker R
    Int J Nurs Stud; 2008 Dec; 45(12):1742-56. PubMed ID: 18701103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Balancing health and industrial policy objectives in the pharmaceutical sector: lessons from Australia.
    Morgan S; McMahon M; Greyson D
    Health Policy; 2008 Aug; 87(2):133-45. PubMed ID: 18295927
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Consumption of prescribed and over-the-counter medicines with prolonged oral clearance used by the elderly in the Northern Region of England, with special regard to generic prescribing, dose form and sugars content.
    Baqir W; Maguire A
    Public Health; 2000 Sep; 114(5):367-73. PubMed ID: 11035458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Do consumers' attitudes predict prescription purchasing behavior?
    Nair KV
    Manag Care Interface; 2003 Jun; 16(6):22-7, 55. PubMed ID: 12841073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.